Surfactant treatment for premature babies--a review of clinical trials.
نویسنده
چکیده
منابع مشابه
Introducing new cost effective treatments into the NHS. Surfactant treatment for premature babies: who cares enough to pay?
The growth in the medicines bill for innovative drugs in the United Kingdom is the lowest in Europe.' Funding new treatments within the NHS is difficult: drug budgets are overspent by significant amounts and mechanisms for obtaining new money for medical advances are simply not working.2 Unless there is a more planned approach to spending on drugs-which takes into account the introduction of ne...
متن کاملThe effects of antenatal corticosteroids and surfactant replacement on neonatal respiratory distress syndrome.
The goal of this study was to determine the effects of antenatal corticosteroids and surfactant replacement on the severity and frequency of Respiratory Distress Syndrome (RDS) in a cohort of premature infants born in Sarajevo, Bosnia and Herzegovina, from 2005 to 2007. The cohort consisted of 172 premature neonates with estimated gestational age between 26 and 34 weeks. Babies with IUGR, babie...
متن کاملNecrotizing Enterocolitis: A dreadful condition of premature babies
NEC is inflammatory necrosis of intestine with most common site being terminal ileum and ascending colon in preterm babies (1). The condition is typically seen in premature infants, and the timing of its onset is generally inversely proportional to the gestational age of the baby at birth, i.e. The earlier a baby is born, longer is the time of risk for NEC in premature babies. The incidence of ...
متن کاملSurfactant administration in premature infants with RDS
Background. The significant advancement in the treatment of respiratory distress syndrome can be attributed to prenatal identification of high risk pregnancies, prevention of illness through antenatal care, prenatal administration of glucocorticoids, advancement in respiratory support and surfactant therapy. These measures resulted in the reduction of mortality and morbidity rates in preterm in...
متن کاملComparison of side effect of survanta and curosurf in decreasing mortality due to respiratory distress syndrome (RDS) in premature infants admitted in NICU of Ghaem Hospital On 2006-2008
Background: Using of natural and synthetic surfactant is a rescue treatment for respiratory distress syndrome. In Iran, Survanta and Curosurf are the most frequent used natural surfactant preparations. We compared the clinical response and safety of two surfactants poractant alpha (Curosurf) and beractant (Survanta) for treatment of respiratory distress syndrome (RDS) in preterm infants. Method...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Archives of disease in childhood
دوره 66 10 شماره
صفحات -
تاریخ انتشار 1991